Information Provided By: 
Fly News Breaks for April 30, 2015
EXAC
Apr 30, 2015 | 07:46 EDT
Canaccord downgraded Exactech to Hold from Buy as its thesis for its main revenue driver, shoulder/extremity, has continued to decelerate and new product introductions have not re-ignited growth in other joint segments. The firm's price target remains $25 on Exactech shares.
News For EXAC From the Last 2 Days
There are no results for your query EXAC
